This bill establishes new Medicare requirements for healthcare providers regarding informed consent and the provision of trained chaperones during sensitive medical procedures.
Lori Trahan
Representative
MA-3
The Protect Patients from Healthcare Abuse Act establishes new Medicare conditions of participation for healthcare providers regarding informed consent and the use of chaperones. This bill mandates that providers must have written policies informing patients of their rights, including the right to request a chaperone during sensitive procedures. Furthermore, it requires staff training on chaperone duties, defining sensitive procedures, and ensuring patients provide informed consent.
If you’ve ever felt uncomfortable during a medical exam—maybe a physical, or something more personal—you know that feeling of vulnerability. The Protect Patients from Healthcare Abuse Act is trying to address that head-on by making some significant changes to how Medicare-participating healthcare providers handle informed consent and intimate procedures, starting January 1, 2026.
This bill essentially sets a new standard for patient safety and autonomy. If a provider wants to bill Medicare, they’ll now have to follow rules that require them to inform every adult patient of their right to informed consent and their right to request a chaperone for a sensitive procedure. Think of it as a mandatory patient bill of rights, specifically focused on procedures where patients are most exposed.
The core of this legislation is the creation of a formal, standardized process around sensitive medical procedures. Providers must now have written policies detailing a patient's right to know the risks, benefits, and alternatives of any service (that’s the Informed Consent part). More importantly, they must inform patients that they can request a chaperone.
A chaperone is defined here as a trained staff member whose job is to be present during a sensitive procedure. Their role is threefold: to act as a witness, ensure a safe and comfortable environment, and report any potential sexual abuse to a supervisor. This formalizes what has often been an informal practice, turning it into a mandatory condition of participation for Medicare.
This is where things get interesting, and potentially a little messy for providers. The bill defines a Sensitive Procedure clearly: any physical exam or procedure involving the genitalia, breasts, perianal region, or rectum. That covers a lot of ground, from routine pap smears to colonoscopies.
But the definition also includes a catch-all: “Any other physical examination, surgery, or other procedure that the individual considers to be sensitive.” This grants the patient the final say, which is great for patient autonomy but could create administrative headaches. For example, if a patient feels uncomfortable with a blood draw due to past trauma and considers it sensitive, the provider must now scramble to find a trained chaperone, even if that procedure isn't typically defined as intimate. This subjective element is a potential point of friction and could lead to inconsistent application across different clinics.
For patients, this bill is a clear win for safety and control. For healthcare providers, it means a significant boost in administrative and training burdens. Every Medicare-participating facility will have to train staff on how to properly perform the functions of a chaperone, what constitutes a sensitive procedure, and how to report abuse. This training costs time and money.
Imagine a busy, understaffed rural clinic. If three patients simultaneously request chaperones for procedures, the clinic needs three trained staff members pulled away from their regular duties to act as witnesses. This could potentially slow down patient flow or, in the worst-case scenario, delay care if a trained chaperone isn't immediately available. While the intent is noble—to protect patients—the practical reality is that it imposes new operational costs that small practices will have to absorb to remain eligible for Medicare payments after the 2026 deadline. Ultimately, this is a necessary step toward better patient protection, but providers will need clear, efficient guidance on implementation to avoid bottlenecks.